Insider Ledger

ASPE insider buying and SEC filings, explained

Aspen Neuroscience, Inc. · CIK 2124080

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Pharmaceutical Preparations
State of incorporation
DE
Fiscal year end
Dec 31

Insider activity in the last 12 months

Bought
$38.0M
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Nov 2, 2026Purchase (code P)Keith Crandell (10% owner) bought 1,333,333 shares directly and indirectly at $15.00 ($20.0M), reported as a purchase (code P). New position of 66,667 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 8 other reporting owners.SEC filing
Filed Nov 2, 2026, 9:50 PM ET
Nov 2, 2026Purchase (code P)Paul L. Berns (10% owner) bought 1,200,000 shares at $15.00 ($18.0M), reported as a purchase (code P). New position of 1,200,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners.SEC filing
Filed Nov 2, 2026, 9:46 PM ET

3 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

2 insiders bought in 30 days

$38.0M in purchases since Nov 2, 2026 · Purchases traded Nov 2, 2026 to Nov 2, 2026 · Active

InsiderValueTradedSource
Paul L. Berns (10% owner)$18.0MNov 2, 2026SEC filing
Keith Crandell (10% owner)$20.0MNov 2, 2026SEC filing

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

FiledItemsTagSource
Nov 2, 2026, 4:49 PM ET
8-K		Bylaws or fiscal-year change (Item 5.03)
Other event (Item 8.01)		SEC filing

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow ASPE in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app